Assessment of a Novel In Situ Forming Wound Dressing for Military Use

摘要

Presented is an evaluation of the biocompatibility and physical properties of a novel hydrogel which cures in situ to form an effective wound dressing. This dressing has the capability of meeting the needs of both the far forward soldier and for use in hospital settings. The GelSpray(Trademark) product platform was developed by BioCure, Inc. Norcross, GA in concert with the Center for Military Biomaterials Research (CeMBR). The GelSpray(Trademark) formulation has been cleared by the US Food & Drug Administration and is indicated for minor cuts and scrapes and minor irritations of the skin. While additional characteristics, such as antimicrobial properties and drug release, and applications for complex wounds are presented in this document, these results are based upon preliminary evaluations and have not been reviewed by the FDA and warrant additional testing.